Therapeutic Asset Ratings
6,369 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Retifanlimab
Breast Neoplasm
BriaCell Therapeutics Corporation
P3
B
(62)
Retifanlimab
Non-Small Cell Lung Carcinoma
University of California, San Diego
P3
B
(62)
Serplulimab
Hepatocellular Carcinoma
Shanghai Henlius Biotech
P3
B
(62)
Serplulimab
Pancreatic Ductal Adenocarcinoma
West China Hospital
P3
B
(62)
Siltuximab
Plasma Cell Myeloma
Institute of Hematology & Blood Diseases Hospital, China
P3
B
(62)
Sugemalimab
Extranodal Nasal NK/T Cell Lymphoma
CStone Pharmaceuticals
P3
B
(62)
Tislelizumab
Colonic Neoplasm
First Affiliated Hospital of Guangxi Medical University
P3
B
(62)
Tislelizumab
Esophageal Adenocarcinoma
BeOne Medicines
P3
B
(62)
Tislelizumab
Immunotherapy
Seventh Medical Center of PLA General Hospital
P3
B
(62)
Tislelizumab
Kidney Cancer
Fudan University
P3
B
(62)
Tocilizumab
Cancer
Genentech, Inc.
P3
B
(62)
Toripalimab
Hormone Receptor-Positive Breast Cancer
First Affiliated Hospital of Zhejiang University
P3
B
(62)
TRASTUZUMAB
Non-Small Cell Lung Carcinoma
Fate Therapeutics
P3
B
(62)
Atezolizumab
Pancreatic Ductal Adenocarcinoma
Genentech, Inc.
P2
B
(62)
Atezolizumab
Female Reproductive Organ Cancer
M.D. Anderson Cancer Center
P2
B
(62)
Atezolizumab
Thoracic Cancer
M.D. Anderson Cancer Center
P2
B
(62)
Atezolizumab
Estrogen-Receptor Positive Breast Cancer
Hoffmann-La Roche
P2
B
(62)
Atezolizumab
Gallbladder Cancer
TransThera Sciences (Nanjing), Inc.
P2
B
(62)
Atezolizumab
Glioblastoma
Centre Hospitalier Universitaire Vaudois
P2
B
(62)
Atezolizumab
Refractory Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)
P2
B
(62)
Balstilimab
Metastatic Colorectal Adenocarcinoma
City of Hope Medical Center
P2
B
(62)
Blinatumomab
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
OHSU Knight Cancer Institute
P2
B
(62)
Botensilimab
Metastatic Colorectal Adenocarcinoma
City of Hope Medical Center
P2
B
(62)
Cetuximab
Anaplastic Astrocytoma
University of Miami
P2
B
(62)
Durvalumab
Nonpapillary Renal Cell Carcinoma
AstraZeneca
P2
B
(62)
Showing 751 to 775 of 6,369 assets
Previous
Page 31 of 255
Next